Skip to main content
Clinical Trials/NCT02285764
NCT02285764
Completed
Not Applicable

NIGO Health- Nutritional Intervention During Gestation and Offspring Health

Abbott Nutrition3 sites in 2 countries331 target enrollmentDecember 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Maternal Glycemia
Sponsor
Abbott Nutrition
Enrollment
331
Locations
3
Primary Endpoint
Maternal Oral Glucose Tolerance Test (OGTT)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this study is to investigate the potential effects of a modified carbohydrate nutritional product for obese pregnant women to reduce maternal glycemia.

Registry
clinicaltrials.gov
Start Date
December 2014
End Date
April 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Voluntarily signed and dated an ICF, approved by an IEC/IRB and provided applicable privacy authorization prior to any participation in the study.
  • Obese (BMI ≥ 30) as determined by pre-pregnancy BMI.
  • ≥18 years of age.
  • ≥15+0 but ≤16+6 weeks gestation with a singleton pregnancy.
  • Willing to follow supplementation protocol and follow appropriate nutritional guidance and refrain from consuming other caloric nutritional supplements that are not approved by the study staff, if applicable.
  • Willing to provide body composition measures on infant at birth.
  • Willing to consider additional measures if follow-up studies are conducted.

Exclusion Criteria

  • Adverse maternal and/or fetal medical history which is expected to alter blood glucose regulations.
  • Previously diagnosed diabetes, previous gestational diabetes, systemic lupus erythematodes, anti-phospholipid syndrome, known renal disease, treated hypertension, uncontrolled hypothyroidism and/or cancer.
  • Taking medications that can impact blood glucose.
  • Previous bariatric surgery.
  • Lactose intolerant and/or has milk protein allergy or requires a special diet regime.
  • Participating in another clinical trial that would impact participation in this study.

Outcomes

Primary Outcomes

Maternal Oral Glucose Tolerance Test (OGTT)

Time Frame: 27-28 weeks gestation

2 hour OGTT

Secondary Outcomes

  • Maternal Fasting Blood Glucose(34-36 weeks gestation)
  • Neonatal Body Composition(Birth - 72 hours)

Study Sites (3)

Loading locations...

Similar Trials